Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mannhalter

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Allergy|April 23, 2014
The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the diseaseG Hoermann, K V Gleixner, G E Dinu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 9, 2007
Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokinesH Abrahamian, G Endler, M Exner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 1998
Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin geneP A Kyrle, C Mannhalter, S Béguin, et al.
British Journal of Haematology|July 1, 1996
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusionF Keil, P Kalhs, O A Haas, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V LeidenI Pabinger, L Nemes, C Rintelen, et al.
Leukemia|August 11, 1998
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosisA Weltermann, I Pabinger, K Geissler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571)H Agis, W R Sperr, S Herndlhofer, et al.
Allergy|April 30, 2013
Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemiaG Hoermann, S Cerny-Reiterer, I Sadovnik, et al.
British Journal of Haematology|November 11, 1999
Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disordersG J Locker, S Kapiotis, M Veitl, et al.
Thrombosis and Haemostasis|May 1, 1997
Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolismP A Kyrle, S Eichinger, I Pabinger, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Allergy|April 23, 2014
The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the diseaseG Hoermann, K V Gleixner, G E Dinu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 9, 2007
Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokinesH Abrahamian, G Endler, M Exner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 1998
Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin geneP A Kyrle, C Mannhalter, S Béguin, et al.
British Journal of Haematology|July 1, 1996
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusionF Keil, P Kalhs, O A Haas, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V LeidenI Pabinger, L Nemes, C Rintelen, et al.
Leukemia|August 11, 1998
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosisA Weltermann, I Pabinger, K Geissler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2007
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571)H Agis, W R Sperr, S Herndlhofer, et al.
Allergy|April 30, 2013
Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemiaG Hoermann, S Cerny-Reiterer, I Sadovnik, et al.
British Journal of Haematology|November 11, 1999
Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disordersG J Locker, S Kapiotis, M Veitl, et al.
Thrombosis and Haemostasis|May 1, 1997
Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolismP A Kyrle, S Eichinger, I Pabinger, et al.
Pageof 19